Epilepsy and Medical Marijuana: Does Cannabis Help with Seizures?
Epilepsy affects approximately 3.4 million Americans and is one of the most common neurological disorders in the world. For patients whose seizures are not adequately controlled by conventional antiepileptic drugs (AEDs), medical cannabis has emerged as a significant area of research and clinical interest. In fact, the connection between cannabis and seizure control is one of the most scientifically documented in the entire field of medical marijuana. If you or someone you care for lives with epilepsy, this guide covers what the research says, which states recognize epilepsy as a qualifying condition, and how Elevate Holistics can help you access legal medical cannabis quickly and easily.
What Is Epilepsy?
Epilepsy is a chronic neurological disorder defined by recurring, unprovoked seizures. A seizure is a sudden burst of abnormal electrical activity in the brain that can cause changes in behavior, movement, sensation, and consciousness. Epilepsy is diagnosed when a person has had at least two unprovoked seizures, or one unprovoked seizure with a high risk of recurrence.
There are more than 30 different types of seizures, broadly classified as focal (originating in one area of the brain) or generalized (involving both hemispheres). Epilepsy syndromes range from relatively mild forms that are easily managed with medication, to severe, treatment-resistant forms like Dravet syndrome and Lennox-Gastaut syndrome that cause multiple daily seizures and significant cognitive impairment.
Standard treatment involves antiepileptic medications, but roughly one-third of people with epilepsy have drug-resistant epilepsy, meaning adequate seizure control cannot be achieved through conventional medications. For these patients, alternative and adjunctive therapies are critically important.
The Endocannabinoid System and Seizure Activity
The brain contains a dense network of endocannabinoid receptors, particularly CB1 receptors, in regions heavily involved in seizure generation and propagation, including the hippocampus, amygdala, and cortex. The endocannabinoid system plays a modulatory role in neuronal excitability. When this system is disrupted, it can contribute to the hyperexcitability that characterizes epilepsy.
Cannabidiol (CBD), a non-intoxicating compound in cannabis, does not primarily bind to CB1 or CB2 receptors. Instead, it acts through multiple mechanisms that are directly relevant to seizure control. CBD modulates voltage-gated sodium and calcium channels, which are the same targets of many conventional AEDs. It also acts at the GPR55 receptor, which when activated promotes neuronal excitability, and CBD appears to block this receptor. Additionally, CBD influences adenosine signaling, which has natural inhibitory effects on neuronal activity.
THC, the psychoactive compound in cannabis, has a more complex relationship with seizure activity. At low doses, THC may provide some anticonvulsant benefit through CB1 receptor activation, but at higher doses it can potentially lower the seizure threshold in some individuals. This is why CBD-dominant formulations are generally preferred for epilepsy management.
We Have a 99% Approval Rate
Medical Cannabis for Pediatric Epilepsy
One of the most emotionally compelling areas of cannabis research involves children with severe, drug-resistant epilepsy. Parents of children with Dravet syndrome and other catastrophic epilepsy syndromes were among the earliest and most vocal advocates for medical cannabis access, particularly after widely reported cases of dramatic seizure reduction following CBD oil treatment.
Several states have specific provisions for pediatric patients with severe epilepsy, often allowing minors to access high-CBD, low-THC preparations with parental consent and physician oversight. If you are a parent seeking medical cannabis options for a child with epilepsy, our physicians can guide you through your state’s specific process and requirements.
What the Research Says
The evidence base for medical cannabis in epilepsy is among the strongest of any condition treated with marijuana. The landmark moment came with the FDA approval of Epidiolex in 2018, a pharmaceutical-grade, plant-derived CBD oral solution. Epidiolex received approval for three specific epilepsy syndromes:
- Dravet syndrome – A severe, treatment-resistant epilepsy beginning in infancy, associated with mutations in the SCN1A gene.
- Lennox-Gastaut syndrome – A serious childhood-onset epilepsy characterized by multiple seizure types and intellectual disability.
- Tuberous sclerosis complex – A genetic disorder that causes benign tumors to grow in the brain and other organs, frequently causing seizures.
The pivotal clinical trials for Epidiolex demonstrated that CBD reduced seizure frequency by approximately 40-50% compared to placebo in patients with Dravet syndrome, and by roughly 43% in patients with Lennox-Gastaut syndrome. These are clinically meaningful reductions for patients who had already failed multiple standard medications.
Beyond Epidiolex, a large body of observational research has examined broader medical cannabis use in epilepsy. A 2017 report by the National Academies of Sciences, Engineering, and Medicine concluded that there is conclusive or substantial evidence that cannabis is effective for the treatment of epilepsy. Patient surveys consistently report meaningful reductions in seizure frequency among users, including adults with various forms of epilepsy beyond the specific syndromes studied in pharmaceutical trials.
What to Expect from a Medical Cannabis Evaluation for Epilepsy
At Elevate Holistics, the process is straightforward and entirely online. During your appointment, a licensed physician will review your epilepsy diagnosis documentation, your current medication regimen, your seizure history, and any other relevant medical history. They will discuss whether medical cannabis is appropriate for you given your specific form of epilepsy, your current medications (interactions are possible, particularly with CBD and certain AEDs), and your state’s qualifying criteria.
If you qualify, you receive a physician certification or recommendation, which you then use to apply for your state medical marijuana card. Many states issue cards quickly, and in some states you can access dispensaries with just the physician certification.
Important Considerations and Drug Interactions
CBD, in particular, has known interactions with several common antiepileptic drugs. CBD can significantly increase blood levels of clobazam (Onfi), a medication commonly used in Lennox-Gastaut syndrome, which can increase sedation and other side effects. CBD can also affect the metabolism of other AEDs including valproic acid and carbamazepine. It is essential to inform both your neurologist and your certifying physician about all medications you take if you pursue medical cannabis for epilepsy.
Starting with a low dose and titrating slowly is strongly recommended, especially in patients already taking multiple AEDs. Regular monitoring and follow-up with your neurologist are important when introducing cannabis as part of an epilepsy management plan.
Forms of Epilepsy That May Qualify
In states where epilepsy is a qualifying condition, the coverage often extends broadly to seizure disorders, including:
- Dravet syndrome
- Lennox-Gastaut syndrome
- Tuberous sclerosis complex
- Temporal lobe epilepsy
- Juvenile myoclonic epilepsy
- Absence epilepsy (in some states, if drug-resistant)
- Focal onset epilepsy
- Post-traumatic epilepsy
- Drug-resistant epilepsy (also called refractory epilepsy)
Most state programs require documented diagnosis from a licensed physician and, in many cases, documentation that standard treatments have been tried without sufficient relief.
States Where Epilepsy Qualifies for Medical Marijuana
Epilepsy and seizure disorders are among the most widely recognized qualifying conditions across U.S. medical marijuana programs. The following states explicitly list epilepsy, seizures, or seizure disorders as qualifying conditions: Alabama, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, Florida, Georgia, Hawaii, Illinois, Louisiana, Maine, Maryland, Michigan, Minnesota, Missouri, Montana, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, Texas (limited CBD program), Utah, Vermont, Virginia, Washington, West Virginia, and Washington D.C.
Some states use broader language such as “neurological conditions,” “treatment-resistant epilepsy,” or “chronic conditions producing seizures,” so it is always important to verify with a licensed physician in your state. Elevate Holistics serves patients across dozens of qualifying states and our physicians are up to date on state-specific requirements.
Get Your Medical Marijuana Card for Epilepsy Today
Living with epilepsy is challenging enough without having barriers to care. At Elevate Holistics, we believe every patient deserves fast, affordable access to legal medical cannabis. Our licensed physicians are available online, appointments typically take 30 minutes or less, and if you are not approved, you pay nothing.
Take the first step toward better seizure management and a higher quality of life. Book your online appointment today and find out if you qualify in your state.
This content is for informational purposes only and does not constitute medical advice. Always consult with a licensed healthcare provider before making changes to your epilepsy treatment plan.
Get Approved for Medical Marijuana Treatment
Frequently Asked Questions About Medical Marijuana and Epilepsy
Is epilepsy a qualifying condition for a medical marijuana card?
Epilepsy and seizure disorders are qualifying conditions for medical marijuana programs in the majority of U.S. states that have medical cannabis laws, including Alabama, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, Florida, Georgia, Illinois, Louisiana, Maryland, Michigan, Minnesota, Missouri, New Jersey, New Mexico, New York, Ohio, Oklahoma, Pennsylvania, Texas, Utah, and West Virginia, among others. State requirements vary, so always confirm with your state health department or a licensed physician.
What does research say about cannabis and epilepsy?
Clinical research strongly supports cannabidiol (CBD) for certain forms of epilepsy. The FDA approved Epidiolex, a plant-derived CBD medication, for Dravet syndrome, Lennox-Gastaut syndrome, and tuberous sclerosis complex following clinical trials showing significant seizure reduction. Broader observational studies on whole-plant cannabis also report seizure frequency improvements in some patients.
How does cannabis help control seizures?
CBD is believed to reduce neuronal excitability by modulating calcium ion channels, sodium channels, and the GPR55 receptor. It also interacts with the endocannabinoid system, helping to regulate neurotransmitter release and reduce the excessive electrical activity that triggers seizures. THC's role in epilepsy is more complex and not universally beneficial.
Can a doctor at Elevate Holistics certify me for epilepsy?
Yes. If you have a documented diagnosis of epilepsy or a seizure disorder and live in a state where epilepsy qualifies, our licensed physicians can evaluate you online and provide a medical marijuana certification or recommendation, often in 30 minutes or less.
What forms of medical cannabis are best for epilepsy?
High-CBD, low-THC formulations are most commonly associated with seizure management based on current evidence. Oils, tinctures, and capsules allow for precise dosing and consistent blood levels, which is important for neurological conditions. Always work with a licensed physician to determine the appropriate formulation and dose.